
|Articles|March 1, 2003
Injectable material promising alternative for reflux
Boston-An injectable tissue-augmenting material is a promising alternativefor the endoscopic treatment of vesicoureteral reflux in children, accordingto researchers from Dublin, Ireland. At follow-up of up to 1 year, refluxwas corrected in 86% of ureters after a single injection of the material,dextranomer/hyaluronic acid copolymer (Deflux, Q-Med, Uppsala, Sweden),according to lead author Prem Puri, MD, pediatric surgeon and director ofresearch at the National Children Hospital in Dublin.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves first-line Zenflow system for the treatment of BPH
2
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
EMA recommends conditional approval of Anktiva in BCG-unresponsive NMIBC
5















